Corrigendum to "Effect of chiglitazar and sitagliptin on glucose variations, insulin resistance and inflammatory-related biomarkers in untreated patients with type 2 diabetes" [Diabetes Res. Clin. Pract. 183 (2022) 109171]. (August 2022) - Wang, Yuming; Li, Huiqin; Gao, Hui; Xu, Xiaohua; Cai, Tingting; Wang, Huiying; Zhou, Yunting; Huang, Rong; Su, Xiaofei; Ma, Jianhua